Skip to content

RIDECLAS: Delphi Classification of RICA Pathway Recommendations

Delphi Study for the Classification of Recommendations for the RICA Pathway (Enhanced Recovery in Adult Surgery)

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07615855
Acronym
RIDECLAS
Enrollment
384
Registered
2026-05-29
Start date
2026-06-01
Completion date
2026-12-31
Last updated
2026-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Enhanced Recovery After Surgery, Perioperative Care, Surgical Care

Keywords

ERAS, Delphi Technique, RICA Pathway, Perioperative Medicine

Brief summary

RIDECLAS is an observational, prospective, non-interventional consensus study using a modified Delphi methodology. The study aims to obtain expert consensus on the classification and final formulation of recommendations for the RICA Pathway, an enhanced recovery pathway for adult surgery. Participants will be healthcare professionals with experience in enhanced recovery, perioperative medicine, surgery, anesthesiology, nursing, rehabilitation, or related disciplines. Experts will complete sequential online questionnaires. Individual responses will remain confidential, and aggregated anonymized feedback will be provided between Delphi rounds. The study does not involve patients, clinical interventions, biological samples, drugs, or medical devices.

Detailed description

This study will use a modified Delphi process conducted remotely through electronic questionnaires. A coordinating committee will prepare an initial list of recommendations based on the previous RICA Pathway document and updated evidence. Expert panelists will rate each recommendation using a 1-to-9 Likert scale and may provide free-text comments. Two Delphi rounds are planned, with a third round if needed for items without sufficient consensus or for reformulated statements. Between rounds, participants will receive aggregated and anonymized feedback, including measures of agreement, median scores, dispersion, and a summary of comments. Consensus for acceptance is predefined as at least 75% of ratings in the 7-9 range and no more than 15% in the 1-3 range. Consensus for rejection is predefined as at least 75% of ratings in the 1-3 range and no more than 15% in the 7-9 range. Items not meeting consensus criteria may be reassessed in subsequent rounds. The analysis will be descriptive and will include response rates, attrition between rounds, item-level agreement, median scores, interquartile ranges, and qualitative thematic review of comments.

Interventions

OTHERModified Delphi questionnaire

Sequential online questionnaires used to rate and classify proposed RICA Pathway recommendations. This is not a clinical intervention and does not involve patient care, drugs, devices, or invasive procedures.

Sponsors

Universidad de Zaragoza
Lead SponsorOTHER
Universidad Miguel Hernandez de Elche
CollaboratorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Healthcare professional or researcher with relevant clinical or scientific experience in enhanced recovery pathways, perioperative medicine, surgery, anesthesiology, nursing, rehabilitation, or related disciplines. At least 5 years of professional experience. Membership in GERM or participation in professional networks related to enhanced recovery in adult surgery. Willingness to participate in the planned Delphi rounds. Provision of electronic informed consent.

Exclusion criteria

* Failure to meet the predefined professional experience criteria. Failure to provide informed consent. Failure to complete the first Delphi round. Duplicate or incomplete responses that cannot be validated for analysis.

Design outcomes

Primary

MeasureTime frameDescription
Expert consensus on RICA Pathway recommendationsThrough study completion, up to 7 monthsConsensus will be assessed for each recommendation using predefined Delphi criteria. Acceptance consensus will be defined as at least 75% of ratings in the 7-9 range and no more than 15% in the 1-3 range. Rejection consensus will be defined as at least 75% of ratings in the 1-3 range and no more than 15% in the 7-9 range.

Secondary

MeasureTime frameDescription
Degree of agreement for each recommendationAfter each Delphi round, up to 7 months.Distribution of ratings, median score, interquartile range, and percentage of ratings in predefined agreement/disagreement ranges.
Stability of ratings between Delphi roundsBetween round 1 and round 2, and round 3 if performed, up to 7 months.Descriptive assessment of changes in item-level ratings and consensus status between rounds.
Response rate and attrition between roundsAfter each Delphi round, up to 7 months.Number and percentage of invited experts who complete each round, and percentage lost between rounds.
Qualitative analysis of expert commentsAfter each Delphi round, up to 7 months.Thematic review of free-text comments to support item reformulation and interpretation of items without consensus.

Countries

Spain

Contacts

CONTACTJosé-Manuel Ramírez Rodríguez, Professor of Surgery
jramirez@unizar.es+34 976 556400

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 30, 2026